retatrutide vs zepbound vs. vs. Wegovy for Weight Loss Retatrutide vs Mounjaro: triple agonist

Our clinical team is here to guide you, monitor your progress, and ensure your treatment is both safe and effective every step of the way

Retatrutide is an investigational once-weekly injectable triple receptor agonist that simultaneously activates GLP-1, GIP, and glucagon receptors to reduce appetite, increase energy expenditure, and improve metabolic function

This snapshot provides a side-by-side summary of the most important performance metrics

Further reading: Retatrutide side effects Note: Retatrutide is currently still undergoing clinical trials and has not been approved for use in the UK by the Medicines and Healthcare products Regulatory Agency (MHRA)

& Jonderko, K